Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126786022 | 12678602 | 2 | F | 20160719 | 20160922 | 20160823 | 20160927 | EXP | FR-009507513-1608FRA011009 | MERCK | 44.70 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126786022 | 12678602 | 1 | PS | EMEND | APREPITANT | 1 | Oral | 125 MG, UNK | U | U | 21549 | 125 | MG | CAPSULE | |||||
| 126786022 | 12678602 | 2 | SS | FUROSEMIDE ACCORD | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | U | 0 | 1 | G | ||||||
| 126786022 | 12678602 | 3 | SS | FUROSEMIDE ACCORD | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | U | 0 | 1 | G | ||||||
| 126786022 | 12678602 | 4 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | U | 0 | 1 | G | ||||||
| 126786022 | 12678602 | 5 | SS | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, UNK | U | U | 0 | 8 | MG | ||||||
| 126786022 | 12678602 | 6 | SS | CORTANCYL | PREDNISONE | 1 | Oral | 60 MG, UNK | U | U | 0 | 60 | MG | ||||||
| 126786022 | 12678602 | 7 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Oral | 200 MG, UNK | U | U | 0 | 200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126786022 | 12678602 | 1 | Prophylaxis of nausea and vomiting |
| 126786022 | 12678602 | 2 | Breast cancer |
| 126786022 | 12678602 | 4 | Breast cancer |
| 126786022 | 12678602 | 5 | Prophylaxis of nausea and vomiting |
| 126786022 | 12678602 | 6 | Prophylaxis of nausea and vomiting |
| 126786022 | 12678602 | 7 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126786022 | 12678602 | OT |
| 126786022 | 12678602 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126786022 | 12678602 | Blood lactic acid increased | |
| 126786022 | 12678602 | Generalised tonic-clonic seizure | |
| 126786022 | 12678602 | Hyperglycaemia | |
| 126786022 | 12678602 | Leukocytosis | |
| 126786022 | 12678602 | Nausea | |
| 126786022 | 12678602 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126786022 | 12678602 | 1 | 20160719 | 0 | ||
| 126786022 | 12678602 | 2 | 20160719 | 0 | ||
| 126786022 | 12678602 | 3 | 20160809 | 0 | ||
| 126786022 | 12678602 | 4 | 20160719 | 0 | ||
| 126786022 | 12678602 | 5 | 20160719 | 0 | ||
| 126786022 | 12678602 | 6 | 20160719 | 0 | ||
| 126786022 | 12678602 | 7 | 20160719 | 0 |